Alex Ky-Miyasaka, MD
Surgery · New York, NYNPI 1154398568
Payments from drug & device makers
Across 268 payments — averaging $189.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Valencia Technologies Corporation$25K
- Boston Scientific$13K
- Bausch Health US, LLC$9K
- Intuitive Surgical$2K
- Axonics, Inc.$909
- Medtronic$451
- plus $592 from 6 others
What the payments were for
- Consulting fees$11,96169%
- Travel & lodging$2,53115%
- Food & beverage$2,76816%
- Gifts$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Valencia Technologies Corporation | 4 | $25,000 |
| Boston Scientific | 7 | $13,121 |
| Bausch Health US, LLC | 216 | $8,569 |
| Intuitive Surgical | 13 | $2,215 |
| Axonics, Inc. | 10 | $909 |
| Medtronic(2 entities) | 8 | $451 |
| TEI Biosciences Inc | 2 | $198 |
| Guard Medical Inc. | 1 | $156 |
| Acell, Inc. | 1 | $91 |
| Merck | 4 | $69 |
| Integra Lifesciences Corporation | 1 | $49 |
| THD America, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$12,751
- Da Vinci Surgical System$1,924
- Bulkamid$672
- Axonics r-SNM System$532
- INTERSTIM$286
- Solyx SIS System$167
- NPseal$156
- NPSEAL LARGE$156
- NPSEAL MEDIUM$156
- SURGIMEND$103
How this compares
$50,858 in reported general payments places this provider in the 90th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 22 | $8,140 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 18 | $1,115 |
| Hydrocortisone | 32 | $306 |
| Procto-Med HcHydrocortisone | 36 | $302 |
| Oxycodone Hcl | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other surgery in New York
- Vinod BalachandranNew York$3M
- Stephanie GoffNew York$2.7M
- Alice WeiNew York$2.3M
- Cheguevara AfanehNew York$1.4M
- Flavio Malcher Martins de OliveiraNew York$814K
- Bonnie LonzeNew York$650K
- Yuri NovitskyNew York$548K
- Rasa ZarnegarNew York$478K
- Tanuja DamaniNew York$459K
- Jatin ShahNew York$451K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.